As per GPI’s PR report, At the 4th International Congress of Movement Disorders of Iran held from August 1st to 3rd, witnessed the participation of Abyan Pharmaceutical Company, a subsidiary of Golrang Pharmaceutical Group. This event provided a platform for Abyan to showcase its latest advancements in the field of neurology and neuroscience.
Abyan presented its innovative medications, namely Lesipak, Leparsid, and Simival, to the medical community. These drugs are specifically designed to treat neurological disorders. Abyan’s presence at this conference demonstrated its unwavering commitment to improving public health and serving patients. The introduction of these specialized medications is a significant step towards Abyan’s pledge to support the medical profession and provide effective treatments for neurological conditions.